Navigation Links
Eurofins MWG Operon launches sequencing service on PacBio RS system
Date:5/25/2011

Ebersberg, Germany, 25 May, 2011 - As one of the pioneers for next generation sequencing (NGS) services, Eurofins MWG Operon has established a solid market reputation as a premium provider of sequencing data in high quality, professional project consulting and innovative developments in library generation and technical strategies. In particular Eurofins MWG Operon's indexed long jumping distance libraries (LJD) for HiSeq 2000 and long paired end (LPE) libraries for GS FLX have shown considerable advantages to allow fast and successful completion of larger projects and de novo sequencing of genomes.

Consistent with its pioneering initiatives, Eurofins MWG Operon has now included the new sequencing platform PacBio RS into its portfolio, further expanding its technological platform available for next generation sequencing services.

"We take specific care to build up a technical and operational pipeline which is suitable to meet our quality standards and the high service level we want to provide to our customers", says Bruno Poddevin, Eurofins Senior Vice President, Genomic Services. "After our evaluation of PacBio RS, we believe that the platform is one of the most promising new NGS technologies on the market. Our team has extensively tested the system using selected bacterial, fungal and higher plant genomes. The most recent technical updates on this machine give way to strobe-sequencing and enable delivery of reads longer than 1500 bp to 2500 bp in a range of more than 10%, while some reads are already longer than 4500 bp. Using this technique, we can develop and offer new strategies to our customers for faster, cheaper and more accurate sequencing of complex genomic data sets."


'/>"/>

Contact: Dr. Georg Gradl
georggradl@eurofins.com
49-809-282-89945
Eurofins MWG Operon
Source:Eurekalert

Page: 1

Related biology news :

1. Eurofins MWG Operon offers advanced de novo genome sequencing
2. Eurofins MWG Operon signs contract to supply DNA sequencing services to Research Councils
3. Eurofins MWG Operon adds Roche GS Junior to its sequencer fleet
4. Eurofins MWG Operon signs contract to supply oligonucleotides to Research Councils
5. Eurofins MWG Operon and Genomatix developed most complete human exome array
6. Eurofins MWG Operon and Genomatix launch strategic alliance
7. Verizon Business to Provide Global IP for Eurofins Scientific
8. Springer launches new open access journal with Korean research society
9. California Academy of Sciences launches scientific expedition to the Philippines
10. UC Berkeley launches Synthetic Biology Institute to advance research in biological engineering
11. Springer launches Journal of Environmental Studies and Sciences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/29/2016)... BioDirection, a privately held medical device company developing novel ... concussion and other traumatic brain injury (TBI), announced today ... the U.S. Food and Drug Administration (FDA) to review ... meeting company representatives reviewed plans for clinical development of ... a planned pilot trial. "We are ...
(Date:11/24/2016)... , Nov. 23, 2016 Cercacor today ... athletes and their trainers non-invasively measure hemoglobin, ... Pulse Rate, and Respiration Rate in approximately 30 seconds. ... users easy and immediate access to key data about ... of a training regimen. Hemoglobin carries ...
(Date:11/19/2016)... -- Securus Technologies, a leading provider of civil and ... and monitoring, announced today that it has offered a ... independent technology judge determine who has the largest and ... calling platform, and the best customer service. ... what we do – which clearly is not the ...
Breaking Biology News(10 mins):
(Date:11/30/2016)... 30, 2016  The Allen Institute for Cell ... first publicly available collection of gene edited, fluorescently ... key cellular structures with unprecedented clarity. Distributed through ... tools are a crucial first step toward visualizing ... what makes human cells healthy and what goes ...
(Date:11/30/2016)... Nov. 30, 2016  Tempus, a technology company ... and Penn,s Abramson Cancer Center have partnered to ... response to immunotherapy treatment based on next generation ... part of a research collaboration, Tempus will provide ... cancer patient data to Penn. Utilizing next-generation sequencing, ...
(Date:11/30/2016)... 2016   Merck , ein führendes ... einer Reihe von Vereinbarungen mit Evotec AG ... Screeningleistungen für Mercks Palette genetischer Reagenzien wie ... diese Bibliotheken in Kombination mit Evotecs Expertise ... zur Ermittlung und Erforschung neuer Arzneimitteltargets.    ...
(Date:11/30/2016)... BILLERICA, Mass. , Nov. 30, 2016   ... announced that it has entered into a set of ... screening services for Merck,s collection of genetic reagents such ... libraries with Evotec,s screening expertise offers an accelerated pathway ... "Drug discovery starts with the identification of new targets, ...
Breaking Biology Technology: